KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹26 Cr | ₹39 Cr | ₹51 Cr | ₹27 Cr | ₹61 Cr |
What is the latest Consolidated Net Profit of KOPRAN ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹26 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹61 Cr |
How is Consolidated Net Profit of KOPRAN Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | -33.26 | |
| Mar2025 | ₹39 Cr | -24.34 | |
| Mar2024 | ₹51 Cr | 87.11 | |
| Mar2023 | ₹27 Cr | -55.38 | |
| Mar2022 | ₹61 Cr | - | |
Compare Consolidated Net Profit of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹949.3 Cr | -1.6% | -2% | 27.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -1.6% |
-2% |
27.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses